Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 14, 2013; 19(38): 6329-6347
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6329
Published online Oct 14, 2013. doi: 10.3748/wjg.v19.i38.6329
No. of FLL | Rate of malignancy | Reference standard | Lesion types | ARFI cut-off (m/s) | QUADAS score | Ref. |
105 | 64.8% | Biopsy, imaging | Haemangioma,FNH, focal fatty sparing, focal fat deposits adenomas, HCC, metastasis | 2.7 | 11 | [182] |
60 | 71.7% | Biopsy, CT/MRI | haemangioma, HCC, CCC, metastasis | 2 | 10 | [183] |
128 | 53.1% | Biopsy, surgery, imaging | Haemangioma, FNH, focal fatty change, abscess, adenoma, solitary necrotic nodule, HCC, metastasis, CCC | 2.2 | 10 | [184] |
42 | 64.3% | Biopsy | Haemangioma, lymphoma, FNH, sarcoid, abscess, focal fatty sparing, HCC, metastasis | 2.5 | 12 | [185] |
45 | 22.2% | Biopsy, CT/MRI | Haemangioma, metastasis | 2.5 | 8 | [186] |
- Citation: Cui XW, Friedrich-Rust M, Molo CD, Ignee A, Schreiber-Dietrich D, Dietrich CF. Liver elastography, comments on EFSUMB elastography guidelines 2013. World J Gastroenterol 2013; 19(38): 6329-6347
- URL: https://www.wjgnet.com/1007-9327/full/v19/i38/6329.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i38.6329